Tumor Markers in Human Biopsy Material

References

• Hofler H. What's new in 'in situ hybridization'. Pathol Res Pract 1987; 182: 421
   PubMedGoogle Scholar
• Fenoglio-Preiser C. M, Willman CL. Molecular biology and the pathologist. General principles and applications. Arch Pathol Lab Med 1987; 111: 601
   PubMed Web of Science ®Google Scholar
• Saiki R. K, Gelfand D. H, Stoffel S., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487
   PubMed Web of Science ®Google Scholar
• Shibata D. K, Arnheim N., Martin WJ. Detection of human papilloma virus in paraffkembedded tissue using the polymerase chain reaction. J Exp Med 1988; 167: 225
   PubMed Web of Science ®Google Scholar
• Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237
   PubMed Web of Science ®Google Scholar
• Teerenhovi L., Knuutila S., Ekblom M. A method for simultaneous study of the karyotype, morphology and immunologic phenotype of mitotic cells in hematologic malignancies. Blood 1984; 64: 1116
   PubMed Web of Science ®Google Scholar
• Tecott L. H, Barchas J. D, Ebenvine JH. In situ hybridization: Specific synthesis of complementary DNA in fixed tissue sections. Science 1988; 240: 1661
   PubMedGoogle Scholar
• Neri A., Knowles D. M, Greco A., McCormick F., Dalla-Fa-Vera R. Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA 1988; 85: 9268
   PubMed Web of Science ®Google Scholar
• Kawasaki E. S, Clark S. S, Coyne M. Y, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia specific mRNA sequences ampliedin vitro. Proc Natl Acad Sci USA 1988; 85: 5698
   PubMed Web of Science ®Google Scholar
• Ohuchi N., Thor A., Page D. L, Hand P. H, Halter S. A, Schlom J. Expression of the 21000 molecular weight RAS protein in spectrum of benign and malignant human mammary tissues. Cancer Res 1986; 46: 2511
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Slamon DJ, Battifora H, Cline MJ. Expression of p21 ras oncoproteins in human cancers. Cancer Res 1986; 46: 1465
   PubMed Web of Science ®Google Scholar
• Lacal J. C, Tronick SR. The ras oncogene. The oncogene handbook, E. P Reddy, A. M Skalka, T. Curran. Elsevier Sci Publ, 1988; 255
   Google Scholar
• Almoguera C., Shibata D., Forrester K., Martin J., Arnheim N., Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549
   PubMed Web of Science ®Google Scholar
• Bos J. L, Fearon E. R, Hamilton S. R, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293
   PubMed Web of Science ®Google Scholar
• Forrester K., Almoguera C., Han K., Grizzle W. E, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298
   PubMed Web of Science ®Google Scholar
• Rodenhuis S., Slebos R. JC, Boot A. JM, et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 1988; 48: 5738
   PubMed Web of Science ®Google Scholar
• Rodenhuis S., van de Wetering M. L, Moot W. J, Evers S. G, van Zandeijk N., Bos JL. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 1987; 317: 929
   PubMed Web of Science ®Google Scholar
• Riou G., Barrois M., Zong-Mei S., Duvillard P., Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 1988; 3: 329
   PubMedGoogle Scholar
• Fujita J., Kraus M. H, Onoue H., et al. Activated H-ras oncogenes in human kidney tumors. Cancer Res 1988; 48: 5251
   PubMedGoogle Scholar
• Janssen J. WG, Steenvoorden A. CM, Lyons J., et al. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA 1987; 84: 9228
   PubMed Web of Science ®Google Scholar
• Kraus M-H., Yuasa Y., Aaronson SA. A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patients. Proc Natl Acad Sci USA 1984; 81: 5384
   PubMed Web of Science ®Google Scholar
• Samowitz W. S, Paull G., Hamilton SR. Reported binding of monoclonal antibody RAP-5 to formalin-fixed tissue sections is not indicative of ras p21 expression. Hum Pathol 1988; 19: 127
   PubMed Web of Science ®Google Scholar
• Varmus HE. The molecular genetics of cellular oncogenes. Ann Rev Genet 1984; 18: 553
   PubMed Web of Science ®Google Scholar
• Shibata D., Fu Y. S, Gupta J. W, Shah K. V, Arnheim N., Martin JW. Methods in laboratory investigation. Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest 1988; 59: 555
   PubMedGoogle Scholar
• Smit V. BM TH, Boot A. JM, Smits A. MM, Fleuren G. J, Cornelisse C. J, Bos JL. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucl Acids Res 1988; 16: 7773
   PubMed Web of Science ®Google Scholar
• Nowell P. C, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497
   Web of Science ®Google Scholar
• Kurzrock R., Gutterman J. UD, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988; 319: 990
   PubMed Web of Science ®Google Scholar
• Bartram C. R, de Klein A., Hagemeijer A., et al. Translocation of the c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 1983; 306: 277
   PubMedGoogle Scholar
• Heisterkamp N., Stephenson J. R, Groffen J., et al. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 1983; 306: 239
   PubMed Web of Science ®Google Scholar
• Konapka J. B, Watanabe S. M, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035
   PubMedGoogle Scholar
• Maxwell S. A, Kurzrock R., Parsons S. J, et al. Analysis of p210ber-abltyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Cancer Res 1987; 47: 1731
   PubMedGoogle Scholar
• McLaughlin J., Chianese E., Witte ON. In vitro transformation of immature hematopoietic cells by the p210ber-abloncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 1987; 84: 6558
   PubMed Web of Science ®Google Scholar
• Boehm T. LJ, Drahovsky D. Application of bcr-specific probe in the classification of human leukaemia. J Cancer Res Clin Oncol 1987; 113: 267
   PubMedGoogle Scholar
• Mills K. I, McKenzie E. D, Birnie GD. The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients. Blood 1988; 72: 1237
   PubMed Web of Science ®Google Scholar
• Croce CM. Role of chromosome translocations in human neoplasia. Cell 1987; 49: 155
   PubMed Web of Science ®Google Scholar
• Bartram C. R, Kleihauer E., de Klein, et al. c-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J 1985; 4: 683
   PubMed Web of Science ®Google Scholar
• Lee M-S., Chang K-S., Freireich E. J, et al. Detection of minimal residual brc/abl transcripts by a modified polymerase chain reaction. Blood 1988; 72: 893
   PubMed Web of Science ®Google Scholar
• Zech L., Haglund U., Nilsson K., Klein K. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 1976; 17: 47
   PubMed Web of Science ®Google Scholar
• Croce C. M, Nowell P. Molecular basis of human B cell neoplasia. Blood 1985; 67: 1
   Google Scholar
• Tsujimoto Y., Cossman J., JafYe E., Croce CM. Involvement of the bcl-2 gene in human follicular lymphomas. Science 1985; 228: 1440
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson M., RafYeld M., Cohen P., Cossman J. Detection of occult follicular lymphoma by specific DNA amplification. Blood 1988; 72: 1822
   PubMed Web of Science ®Google Scholar
• Berliner N., Ault K. M, Martin P., Weinberg DS. Detection of clonal excess in lymphoproliferative disease by Kappa/ Lambda analysis: Correlation with immunoglobulin gene DNA rearrangement. Blood 1986; 67: 80
   PubMed Web of Science ®Google Scholar
• Cleary M. L, Chao M., Warnke R., Sklar J. Immunoglobulin gene rearrangement as a diagnosis criterion of 8-cell lymphoma. Proc Natl Acad Sci USA 1984; 81: 593
   PubMed Web of Science ®Google Scholar
• Minden M. D, Mak TW. The structure of the T-cell antigen receptor genes in normal and malignant T-cells. Blood 1986; 68: 327
   PubMed Web of Science ®Google Scholar
• Arnold A., Cossman J., Bakhshi A., Jaffe E. S, Waldman T. A, Korsmeyer SJ. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983; 309: 1593
   PubMed Web of Science ®Google Scholar
• O'Connor N. TJ, Gatter K. C, Wainscoat J. S, et al. Practical value of genotypic analysis for diagnosing lymphoproliferative disorders. J Clin Pathol 1986; 40: 147
   Google Scholar
• Fishleder A., Tubbs R., Hesse B., Levine H. Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 1987; 316: 1118
   PubMed Web of Science ®Google Scholar
• Cossman J., Uppenkamp M., Sundeen J., Coupland R., Raffeld M. Molecular genetics and diagnosis of lymphoma. Arch Pathol Lab Med 1988; 112: 117
   PubMed Web of Science ®Google Scholar
• Knudson AG, Jr. Genetics of human cancer. Ann Rev Genet 1986; 20: 231
   PubMed Web of Science ®Google Scholar
• Friend S. H, Dryja T. P, Weinberg RA. Oncogenes and tumor—suppressing genes. N Engl J Med 1988; 318: 618
   PubMed Web of Science ®Google Scholar
• Klein G. The approaching era of the tumor suppressor genes. Science 1987; 238: 1539
   PubMed Web of Science ®Google Scholar
• Ponder B. Gene losses in human tumors. Nature 1988; 335: 400
   PubMed Web of Science ®Google Scholar
• Green MR. When the products of oncogenes and anti-oncogenes meet. Cell 1989; 56: 1
   PubMed Web of Science ®Google Scholar
• Lee W. H, Boosktein R., Hong F., Young L-J, Shew J-Y, Lee EY-HP. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 1987; 235: 1394
   PubMed Web of Science ®Google Scholar
• Lee W-H., Shew J-Y., Hong F. D, et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329: 642
   PubMed Web of Science ®Google Scholar
• Moll R., Franke W. W, Schiller D. L, Geiger B., Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11
   PubMed Web of Science ®Google Scholar
• Tseng S. CG, Jarvinen M. J, Nelson W. G, Huang J-W, Woodcock-Mitchell J., Sun TT. Correlation of specific keratins with different types of epithelial differentiation: Monoclonal antibody studies. Cell 1982; 30: 361
   PubMed Web of Science ®Google Scholar
• Battifora H. The biology of the keratins and their diagnostic applications. Advances in immunohistochemistry, R. A DeLellis. Raven Press, New York 1988; 191
   Google Scholar
• Osborn M., Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 1983; 48: 372
   PubMed Web of Science ®Google Scholar
• Virtanen I., Miettinen M., Lehto V-P, Kariniemi A-L, Paasivuo R. Diagnostic application of monoclonal antibodies to intermediate filaments. Ann NY Acad Sci 1985; 455: 635
   PubMed Web of Science ®Google Scholar
• Schegel R., Banks-Schlegel S., McLeod J. A, Pinkus GS. Immunoperoxidase localization of keratin in human neoplasms. Am J Pathol 1980; 101: 41
   PubMedGoogle Scholar
• Cooper D., Schemer A., Sunt T-T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations. Lab Invest 1985; 52: 243
   PubMed Web of Science ®Google Scholar
• Lehto V-P., Virtanen I. Antibodies to intermediate filaments in the diagnosis of cancer. Cancer Rev 1986; 6: 1
   Google Scholar
• Ramaekers F., Haag D., Jap P., Vooijs PG. Imrnunochemical demonstration of keratin and vimentin in cytologic aspirates. Acta Cytol 1984; 28: 385
   PubMed Web of Science ®Google Scholar
• Ramaekers F., Huysmans A., Moesker O., et al. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest 1983; 49: 353
   PubMed Web of Science ®Google Scholar
• Lehto V-P., Bergh J., Virtanen I. Immunohistology in the classification of lung cancer. Lung cancer: Basic and clinical aspects, H. H Hansen. Martinus Nijhoff, Boston 1986; 1
   Google Scholar
• Quinlan R. A, Schiller D. L, Halzfeld M., et al. Patterns of expression of cytokeratin intermediate filaments. Ann NY Acad Sci 1986; 45: 282
   Google Scholar
• Miettinen M., Lehto V-P, Virtanen I. Nasopharyngeal lymphoid epithelioma: Histological diagnosis as aided by immunohistochemical demonstration of keratin. Virchows Arch (B) 1982; 4: 337
   Google Scholar
• Miettinen M., Partanen S., Lehto V-P, Virtanen I. Mediastinal tumors: Ultrastructural and immunohistochemical evaluation of intermediate filaments as diagnostic aids. Ultrastruct Pathol 1983; 4: 337
   PubMed Web of Science ®Google Scholar
• Battifora H., Sun T-T, Bahu R. M, Rao S. The use of antikeratin antiserum as a diagnostic tool: Thymoma versus lymphomas. Hum Pathol 1980; 11: 635
   PubMed Web of Science ®Google Scholar
• Battifora H., Sheibani K., Tubbs R. R, Kopinski M., Sun TT. Antikeratin antibodies in tumor diagnosis. Distinction between seminoma and embryonal carcinoma. Cancer 1984; 54: 843
   PubMed Web of Science ®Google Scholar
• Miettinen M., Virtanen I., Talerman A. Intermediate filament proteins in human testis and testicular germ cell tumors. Am J Pathol 1985; 120: 402
   PubMed Web of Science ®Google Scholar
• Hofler H., Kerl H., Lackinger E., Helbeis G., Denk H. The intermediate filament cytoskeleton of cutaneous neuroendocrine carcinoma (Merkel cell tumor). Virchows Arch (A) 1985; 406: 339
   Google Scholar
• Miettinen M., Lehto V-P, Dahl D., Virtanen I. Differential diagnosis of chordoma, chondroid and ependymal tumors as aided by anti-intermediated filament antibodies. Am J Pathol 1983; 112: 160
   PubMed Web of Science ®Google Scholar
• Miettinen M., Lehto V-P, Virtanen I. Keratin in epithelia-like cells of classical biphasic synovial sarcoma. Virchows Arch (B) 1982; 40: 157
   Web of Science ®Google Scholar
• Miettinen M., Lehto V-P, Virtanen I. Presence of fibroblasttype intermediate filaments (vimentin) and absence of neurofdaments in pigmented nevi and malignant melanomas. J Cutan Pathol 1983; 10: 188
   PubMedGoogle Scholar
• Caselitz J., Janner M., Breitbart E., Weber K., Osborn M. Malignant melanomas contain only the vimentin type of intermediate filaments (Implications for histogenesis and diagnosis). Virchows Arch (A) 1983; 400: 43
   Web of Science ®Google Scholar
• Brown D. C, Theaker J. M, Banks P. M, Gatter K. C, Mason DY. Cytokeratin expression in smooth muscle and smooth muscle tumors. Histopathology 1987; 11: 477
   PubMed Web of Science ®Google Scholar
• Wotherspoon A. C, Norton A. C, Isaacson PG. Immunoreactive cytokeratins in plasmacytomas. Histopathology 1989; 14: 141
   PubMed Web of Science ®Google Scholar
• Chase D. R, Enzinger F. M, Weiss S. W, Langloss JM. Keratin in epithelioid sarcoma. An immunohistochemical study. Am J Surg Pathol 1984; 8: 435
   PubMed Web of Science ®Google Scholar
• Franke W. W, Moll R. Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils and spleen. Differentiation 1987; 36: 145
   PubMed Web of Science ®Google Scholar
• Cown P., Kapprell H-P, Franke WW. The complement of desmosomal plaque proteins in different cell types. J Cell Biol 1985; 101: 1442
   PubMedGoogle Scholar
• Franke W. W, Moll R., Mueller H., et al. Immunocytochemical identification of epithelium-derived human tumor with antibodies to desmosomal plaque proteins. Proc Natl Acad Sci USA 1983; 80: 543
   PubMed Web of Science ®Google Scholar
• Moll R., Cowin P., Kapprell H-P, Franke WW. Desmosomal proteins: New markers for identification and classification of tumors. Lab Invest 1986; 54: 4
   PubMed Web of Science ®Google Scholar
• Panish E. P, Streat P. V, Garrod D. R, Weller RO. Antidesmosomal monoclonal antibody in the diagnosis of intracranial tumours. J Pathol 1987; 153: 265
   PubMedGoogle Scholar
• Denk H., Moll R., Weybora W., et al. Intermediate filaments ind desmosomal plaque proteins in testicular seminomas and non-seminomatous germ cell tumours as revealed by immunohistochemistry. Virchows Arch (A) 1989; 410: 295
   Google Scholar
• Imam A., Drushella M. M, Taylor C. R, Tokes ZA. Preferential expression of a M, 150000 milk-fat-globule membrane glycoprotein on luminal epithelium of lobules in human breast. Cancer Res 1986; 46: 6374
   PubMed Web of Science ®Google Scholar
• Taylor-Papadimitriou J., Peterson J., Arklie J., Burchell J., Ceriani R., Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with the cells in culture. Int J Cancer 1981; 28: 17
   PubMed Web of Science ®Google Scholar
• Heyderman E., Steele K., Ormerod MG. A new antigen on the epithelial membrane: its immunoperoxidase localization in normal and neoplastic tissue. J Clin Pathol 1979; 32: 35
   PubMed Web of Science ®Google Scholar
• Ceriani R. L, Thompson K., Peterson J., Abraham S. Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc Natl Acad Sci USA 1977; 74: 582
   PubMed Web of Science ®Google Scholar
• Heyderman E., MacCartney JC. Epithelial membrane antigens and lymphoid cells. Lancet 1985; 1: 109
   PubMedGoogle Scholar
• Wells C. A, Heryet A., Brochier J., Katter K., Masson D. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984; 50: 193
   PubMed Web of Science ®Google Scholar
• Sloane J. P, Ormerod MG. Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer 1981; 47: 1786
   PubMed Web of Science ®Google Scholar
• Forsman L., Karhi K., Autero N., Gahnberg C., Andersson L. Antiserum against formalin-fixed human milk-fat-globule like protein for immunohistochemistry in normal and malignant apocrine epithelium. Acta Pathol Microbiol Immunol Scand(A) 1984; 92: 331
   PubMedGoogle Scholar
• Ashorn P., Helle M., Helin H., Ashorn R., Krohn K. Use of immunohistochemical staining banel for characterization of ovarian neoplasms. J Clin Pathol 1988; 41: 12
   PubMedGoogle Scholar
• Pinkus G. S, Curtin PJ. Epithelial membrane antigen—A diagnostic discriminant in surgical pathology. Immunohistochemical profile in epithelial, mesenchymal and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 1985; 16: 929
   PubMed Web of Science ®Google Scholar
• Wick M. R, Manivel JC. Epithelioid sarcoma and epithelioid hemangioendothelioma: An immunocytochemical and lectin-histochemical comparison. Virchows Arch (A) 1987; 410: 309
   Google Scholar
• Miettinen M. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma. Arch Pathol Lab Med 1988; 112: 637
   PubMed Web of Science ®Google Scholar
• Thomas P., Battifora H. Keratins versus epithelial membrane antigen in tumor diagnosis: an immunohistochemical comparison of five monoclonal antibodies. Hum Pathol 1987; 18: 728
   PubMed Web of Science ®Google Scholar
• Kobsis A. C, De Vries G. P, Meijer A. EFH, Ploem JS. The immunohistochemical detection of prostatic acid phosphatase: Its possibilities and limitations in tumours histochemistry. Histochem J 1981; 13: 961
   PubMedGoogle Scholar
• Yam L. T, Janckila A. J, Lam W. KW, Li CY. Immunohistochemistry of prostatic acid phosphatase. Prostate 1981; 2: 97
   PubMedGoogle Scholar
• Nadji M., Tabei S. Z, Castro A., et al. Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms. Cancer 1981; 48: 1229
   PubMed Web of Science ®Google Scholar
• Sobin L. H, Hjermstad B. M, Sesterhenn I. A, Helwig EB. Prostatic acid phosphatase activity in carcinoid tumors. Cancer 1986; 58: 136
   PubMed Web of Science ®Google Scholar
• Pontes JE. Biological markers in prostate cancer. J Urol 1983; 130: 1037
   PubMed Web of Science ®Google Scholar
• Allhoff E. P, Proppe K. H, Chapman C. M, Lin C-W, Prout G-R, Jr. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer. J Urol 1983; 129: 315
   PubMed Web of Science ®Google Scholar
• Feiner H. D, Gonzales R. Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates. Am J Surg Pathol 1986; 10: 765
   PubMedGoogle Scholar
• Eng L. F. Chemical characterization of the glial fibrillary acidic protein. Fed Proc 1973; 32: 485
   Google Scholar
• Bignami A., Schoene C. Glial fibrillary acidic protein in human brain tumors. Immunocytochemistry, R. De Lellis. Masson, New York 1981; 213
   Google Scholar
• Perents E., Rubinstein LJ. Recent applications of immunoperoxidase histochemistry in human neuro-oncology. An update. Arch Pathol Lab Med 1987; 111: 796
   PubMedGoogle Scholar
• Deck J. HN, Eng L. F, Bigbee J., Woodcock SM. The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors. Acta Neuropathol 1978; 42: 183
   PubMedGoogle Scholar
• Sarkar C., Roy S., Tandon PN. Oligodendroglial tumors. An immunohistochemical and electron microscopic study. Cancer 1988; 61: 1862
   PubMed Web of Science ®Google Scholar
• Collins VP. Monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors. Acta Cytol 1984; 28: 401
   PubMed Web of Science ®Google Scholar
• Tascos N. A, Parr J., Gonatas NK. Immunocytochemical study of glial fibrillary acidic protein in human neoplasms of the central nervous system. Hum Pathol 1982; 13: 454
   PubMed Web of Science ®Google Scholar
• Budka H. Non-glial specificities of immunohistochemistry for the glial fibrillary acidic protein (GFAP). Triple expression of GFAP, vimentin and cytokeratins in papillary meningioma and metastasizing renal carcinoma. Acta Neuropathol 1986; 72: 43
   PubMed Web of Science ®Google Scholar
• Achstäffer T., Moll R., Anderson A., et al. Expression of glial filament protein (GFP) in nerve sheaths and non-neuronal cells re-examined using monoclonal antibodies, with special emphasis on the co-expression of GFAP and cytokeratins in epithelial cells of human salivary glands and pleomorphic adenomas. Differentiation 1986; 31: 206
   PubMedGoogle Scholar
• Lee VM-Y, Wu H-L, Schlaepfer WW. Monoclonal antibodies recognize individual neurofilament triplet proteins. Proc Natl Acad Sci USA 1982; 79: 6089
   PubMedGoogle Scholar
• Ttojanowski JQ. Immunohistochemistry of neurofilament proteins and their diagnostic applications. Advances in immunohistochemistry, R. A DeLellis. Raven Press, New York 1988; 237
   Google Scholar
• Lehto V-P., Miettinen M., Virtanen I. A dual expression of cytokeratin and neurofilaments in bronchial carcinoid cells. Int J Cancer 1985; 35: 421
   PubMed Web of Science ®Google Scholar
• Miettinen M., Lehto V-P, Dahl D., Virtanen I. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract. Lab Invest 1985; 52: 429
   PubMed Web of Science ®Google Scholar
• Bishop A. E, Polak J. M, Facer P., Fem G-L, Marangos P. J, Pearse A. GE. Neuron-specific enolase: A common marker for the endocrine cells and innervation of the gut and pancreas. Gastroenterology 1982; 83: 902
   PubMed Web of Science ®Google Scholar
• Marangos P. J, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Ann Rev Neurosci 1987; 10: 269
   PubMed Web of Science ®Google Scholar
• Carlei F., Polak JM. Antibodies to neuron-specifc enolase for the delineation of the entire diffuse neuroendocrine system in health and disease. Semin Diagn Pathol 1984; 1: 59
   PubMedGoogle Scholar
• Haimoto H., Takahashi Y., Koshikawa T., Nagura H., Kato K. Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 1985; 52: 257
   PubMed Web of Science ®Google Scholar
• Dranoff G., Pikner DD. A word of caution in the use of neuron-specific enolase expression in tumor diagnosis. Arch Pathol Lab Med 1984; 182: 535
   Google Scholar
• Schmechel D. Gamma subunit of the glycolytic enzyme enolase: Non-specific or neuron-specific. Lab Invest 1985; 52: 239
   PubMed Web of Science ®Google Scholar
• Wilson B. S, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984; 115: 458
   PubMed Web of Science ®Google Scholar
• O'Connor D. T, Burton D., Deftos LJ. Chromogranin A: Immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine gland. Life Sci 1983; 33: 1657
   PubMedGoogle Scholar
• Korr S. U, Kumarasamy R., Dean V. N, Cohn DV. New suggestions for the physiological role of secretory protein 1. Bone Miner 1987; 2: 251
   PubMedGoogle Scholar
• Lloyd RV. Immunohistochemical localization of catecholamines, catecholamine synthesizing enzymes, and chromo-granins in neuroendocrine cells and tumors. Advances in immunohistochemistry, R. A DeLellis. Raven Press, New York 1988; 317
   Google Scholar
• O'Connor D. T, Burton D., Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Invest 1983; 57: 1084
   Google Scholar
• Sobol R. E, Memoli V., Deftos LJ. Hormone-negative chromogranin A-positive endocrine tumors. N Engl J Med 1988; 320: 444
   Google Scholar
• Helman L. J, Gazdar A. F, Park J-G, Cohen P. S, Cotelingam J. D, Israel MA. Chromogranin A expression in normal and malignant human tissues. J Clin Invest 1988; 82: 686
   PubMedGoogle Scholar
• Eriksson B., Arnberg H., Oberg K., et al. Chromogranins—New sensitive markers for neuroendocrine tumors. Acta Oncol 1989; 28: 325
   PubMed Web of Science ®Google Scholar
• O'Connor D. T, Deftos LJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986; 314: 1145
   PubMed Web of Science ®Google Scholar
• Sobol R. E, O'Connor D. T, Addision J., Suchocki K., Royston I., Deftos LJ. Elevated serum chromogranin A concentrations in small cell lung carcinoma. Ann Intern Med 1986; 105: 698
   PubMed Web of Science ®Google Scholar
• Gould V. E, Lee I., Wiedenmann B., Moll R., Chejfec G., Franke WW. Synaptophysin: A novel marker for neurons, certain neuroendocrine cells and their neoplasms. Hum Pathol 1986; 17: 979
   PubMed Web of Science ®Google Scholar
• Wiedermann B., Franke W. W, Kuhn C., Moll R., Gould VE. Synaptophysin: A marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA 1986; 83: 3500
   PubMed Web of Science ®Google Scholar
• Buffa R., Rindi G., Cessa F., et al. Synaptophysin immunore-activity and small clear vesicles in neuroendocrine cells and related tumors. Mol Cell Probes 1988; 2: 367
   Google Scholar
• Vanstapel M-J., Gatter K. C, de Wolf-Peeters C., Mason D. Y, Desmet VD. New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol 1986; 85: 160
   PubMed Web of Science ®Google Scholar
• Haimoto H., Hosoda S., Kato K. Differential distribution of immunoreactive S-100–α and S-100–β proteins in normal non-nervous human tissues. Lab Invest 1987; 57: 489
   PubMed Web of Science ®Google Scholar
• Vinores S. A, Bonnin J. M, Rubinstein L. J, Marangos PJ. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med 1984; 108: 536
   PubMed Web of Science ®Google Scholar
• Cochran A. J, Wen DR. S-100 protein as a marker for melanocytic and other tumours. Pathology 1985; 176: 340
   Google Scholar
• Gatter K. C, Ralfkiger E., Skinner J., et al. An immunocyto-chemical study of malignant melanoma and its differential diagnosis from other malignant tumors. J Clin Pathol 1985; 88: 1353
   Google Scholar
• Drier J. K, Swanson P. E, Cherwitz D. L, Wick MR. S-100 protein immunoreactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma. Arch Pathol Lab Med 1987; 111: 447
   PubMedGoogle Scholar
• Bishop A. E, Power R. F, Polak JM. Markers for neuroendocrine differentiation. Pathol Res Pract 1988; 183: 119
   PubMedGoogle Scholar
• DeLellis RA. Endocrine tumors. Diagnostic immunopathology, R. P Colvin, A. K Bhan, R. T McCluskey. Raven Press, New York 1988; 301
   Google Scholar
• Klöppel G., Heitz PU. Pancreatic endocrine tumors. Pathol Res Pract 1988; 183: 155
   PubMedGoogle Scholar
• Lazarides E., Hubbard BD. Immunological characterization of the subunit of the 100 filaments from muscle cells. Proc Natl Acad Sci USA 1976; 73: 4344
   PubMed Web of Science ®Google Scholar
• Dahl D., Zapatka S., Bignami A. Heterogeneity of desmin, the muscle-type intermediate filament protein, in blood vessels and astrocytes. Histochemistry 1982; 84: 145
   Google Scholar
• Burt A. D, Robertson J. L, Heir J., MacSween R. NM. Desmin-containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury. J Pathol 1986; 150: 29
   PubMedGoogle Scholar
• Miettinen M., Lehto V-P, Badley R. A, Virtanen I. Alveolar rhabdomyosarcoma. Demonstration of the muscle type of intermediate filament protein, desmin, as a diagnostic aid. Am J Pathol 1982; 108: 246
   PubMed Web of Science ®Google Scholar
• Molenaar W. M, Oosterhuis J. W, Ramaekers F. CS. Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas. Hum Pathol 1985; 16: 838
   PubMed Web of Science ®Google Scholar
• Ceccarelli C., Eusebi V., Bussolati G. Desmin and sarcomeric myosins in the diagnosis of rhabdomyosarcomas. Advances in immunohistochemistry, RA DeLellis. Raven Press, New York 1988; 223
   Google Scholar
• Huitfeldt H. S, Brandtzaeg P. Various keratin antibodies produce immunohistochemical staining of human myocardium and myometrium. Histochemistry 1985; 83: 381
   PubMedGoogle Scholar
• Gown A. M, Boyd H. C, Chang Y., Ferguson M., Reichler B., Tippens D. Smooth muscle cells can express cytokeratins of 'Simple' epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol 1988; 1932: 223
   Google Scholar
• Lazarides E. Intermediate filaments: A chemically heterogeneous developmentally regulated class of proteins. Ann Rev Biochem 1982; 51: 219
   PubMed Web of Science ®Google Scholar
• Virtanen I., Lehto V-P, Lehtonen E., et al. Expression of intermediate filaments in cultured cells. J Cell Sci 1981; 50: 45
   PubMed Web of Science ®Google Scholar
• Miettinen M., Lehto V-P, Badley R. A, Virtanen I. Expression of intermediate filaments in soft tissue sarcomas. Int J Cancer 1982; 30: 541
   PubMed Web of Science ®Google Scholar
• Miettinen M., Lehto V-P, Virtanen I. Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastruct Pathol 1984; 7: 83
   PubMed Web of Science ®Google Scholar
• Wick M. R, Swanson PE. Soft tissue tumors. Diagnostic immunopathology, R. B Colvin, A. K Bhan, R. T McCluskey. Raven Press, New York 1988; 365
   Google Scholar
• Azumi N., Battifora H. The distribution of vimentin and keratin in epithelial and non-epithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol 1987; 88: 286
   PubMed Web of Science ®Google Scholar
• McNutt M. A, Bolen J. W, Cown A. M, Hammar S. P, Vogel AM. Coexpression of intermediate filaments in human epithelial neoplasms. Ultrastruct Pathol 1985; 9: 31
   PubMed Web of Science ®Google Scholar
• Ramaekers F. CS, Haag D., Kant A., Moesker O., Jap P. HK, Vooijs GP. Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA 1983; 80: 2618
   PubMed Web of Science ®Google Scholar
• Mukai K., Rosai J., Halloway P. Localization of myoglobin in normal and neoplastic human skeletal muscle cells using an immunoperoxidase method. Am J Surg Pathol 1979; 3: 373
   PubMed Web of Science ®Google Scholar
• Mukai K., Varela-Duran J., Nochomovitz LE. The rhabdo-myoblast in mixed miillerian tumors of the uterus and ovary: An immunohistochemical study of myoglobin in 25 cases. Am J Clin Pathol 1980; 74: 101
   PubMedGoogle Scholar
• Corson J., Pinkus G. Intracellular myoglobin: A specific marker for skeletal muscle differentiation in soft tissue sarcomas: An immunoperoxidase study. Am J Pathol 1981; 103: 384
   PubMedGoogle Scholar
• Brooks JJ. Immunohistochemistry of soft tissue tumors: Progress and prospects. Hum Pathol 1982; 13: 969
   PubMed Web of Science ®Google Scholar
• Leader M., Patel J., Collins M., Henry K. Myoglobin: an evaluation of its role as a marker of rhabdomyosarcomas. Br J Cancer 1989; 59: 106
   PubMedGoogle Scholar
• Miettinen M. Antibody specific to muscle actins in the diagnosis and classification of soft tissue tumors. Am J Pathol 1988; 130: 205
   PubMed Web of Science ®Google Scholar
• Benzonana G., Skalli O., Gabbiani G. Correlation of smooth muscle or non-muscle myosins and α-smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton 1988; 11: 260
   PubMed Web of Science ®Google Scholar
• Schurch W., Skalli O., Seemayer T. A, Gabbiani G. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. Am J Pathol 1987; 128: 91
   PubMed Web of Science ®Google Scholar
• Skalli O., Gabbiani G., Babai F., Seemayer T. A, Pizzalato G., Schurch W. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am J Pathol 1988; 130: 515
   PubMed Web of Science ®Google Scholar
• Jaffe E. A, Hoyer L. W, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothetial cells. J Clin Invest 1973; 52: 2757
   PubMedGoogle Scholar
• Hoyer L. W, De Los Santos R. P, Hoyer JR. Antihemophilic factor antigen. Localization in endothelial cells by immuno-fluorescent microscopy. J Clin Invest 1973; 52: 2737
   PubMed Web of Science ®Google Scholar
• Guarda L. A, Ordonez N. G, Smith JL, Jr, Hanssen G. Immunoperoxidase localization of factor VIII in angiosarcomas. Arch Pathol Lab Med 1982; 106: 515
   PubMed Web of Science ®Google Scholar
• Wick M. R, Manivel JC. Epithelioid sarcoma and epithelioid hemangioendothelioma: An immunohistological and lectin-histochemical comparison. Virchows Arch (A) 1987; 410: 309
   Google Scholar
• Miettinen M., Lehto V-P, Virtanen I. Postmastectomy angiosarcoma (Stewart-Treves syndrome): Light microscopic, immunohistological, and ultrastructural characteristics of two cases. Am J Surg Pathol 1983; 7: 329
   PubMedGoogle Scholar
• Miettinen M., Holthofer H., Lehto V-P, Miettinen A., Virtanen I. Ulex Europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol 1983; 79: 32
   PubMedGoogle Scholar
• Ordonˆez N. G, Batsakis JG. Comparison of Ulex-Europaeus I lectin and factor VIII-related antigen in vascular lesions. Arch Pathol Lab Med 1984; 108: 129
   PubMed Web of Science ®Google Scholar
• Russell M., Jones R., Spaull J., Spry C. JF, Wilson-Jones E. Histogenesis of Kaposi's sarcoma in patients with and without AIDS. J Clin Pathol 1986; 39: 742
   PubMedGoogle Scholar
• Holthöfer H., Virtanen I., Kariniemi A-L, Hormia M., Linder E., Miettinen A. Ulex Europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest 1982; 47: 60
   PubMed Web of Science ®Google Scholar
• Yonezawa S., Nakamura T., Tanaka S., Sato E. Glycoconjugate with Ulex Europaeus I agglutinin-I-binding sites in normal mucosa, adenoma and carcinoma of the human large bowel. J Natl Cancer Inst 1982; 69: 777
   PubMedGoogle Scholar
• Allroy J., Ucci A. A, Periera N. EA. Lectin histochemistry: an update. Advances in irnmunohistochemistry, R. A DeLellis. Raven Press, New York 1988; 93
   Google Scholar
• Nagakima T., Watanabe S., Sato Y., Kameya T., Shimosato Y., Lshihara K. Immunohistochemical demonstration of S100-protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 1982; 50: 192
   Google Scholar
• Natal P. G, Cavaliere R., Matsui M., Buraggi G., Callgano L., Ferrone S. Human melanoma associated antigens identified with monoclonal antibodies: Characterization and potential clinical application. Cutaneous melanoma and precursor lesions, D. J Ruiten, K. Welvaart, S. Ferrone. Martin Nijhoff, Boston 1984; 19
   Google Scholar
• Ordonez M. G, Xiaolung J. I, Hickey RA. Comparison of HM8–45 monoclonal antibody and S100-protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 1988; 90: 385
   PubMedGoogle Scholar
• Wick M. R, Swanson P. E, Manivel JC. Immunohistochemical findings in tumors of the skin. Advances in immunohistochemistry, R. A DeLellis. Raven Press, New York 1988; 395
   Google Scholar
• Gold P., Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439
   PubMed Web of Science ®Google Scholar
• Bhan AK. Differentiation antigen as strategies in tumor diagnosis. Diagnostic immunopathology, R. P Colvin, A. K Bhan, R. T McCluskey. Raven Press, New York 1988; 199
   Google Scholar
• Battifora H., Kopinski NI. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer 1985; 55: 1679
   PubMed Web of Science ®Google Scholar
• Corson J. M, Pinkus GS. Mesothelioma: Profile of keratin proteins and carcinoembryonic antigen: An immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol 1982; 108: 80
   PubMed Web of Science ®Google Scholar
• Charpin C., Bhan A. K, Zurawski VR, Jr, Scully RE. Carcinoembryonic antigen (CEA) and carbohydrate detenninant 19–9 (CEA 19–9) localization in 121 primary metastatic ovarian tumors: An immunohistochemical study with the use of monoclonal antibodies. Int J Gynecol Pathol 1982; 1: 231
   PubMedGoogle Scholar
• Buchegger F., Schreyer M., Carrel S., Mach JP. Monoclonal antibodies identify a CEA cross-reacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. Int J Cancer 1984; 33: 643
   PubMed Web of Science ®Google Scholar
• Muraro R., Wunderlich D., Thor A., et al. Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res 1985; 45: 5769
   PubMed Web of Science ®Google Scholar
• von Kleist S., Chavanel G., Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci USA 1972; 69: 2492
   PubMedGoogle Scholar
• Primus F. J, Newell K. D, Blue A., Goldenberg DN. Immunological heterogeneity of carcinoembryonic antigen: Antigenic determinant on carcinoembryonic antigen distinguished by monoclonal antibodies. Cancer Res 1983; 43: 686
   PubMed Web of Science ®Google Scholar
• Thor A., Simpson J., Ohuchi N., . Monoclonal antibodies and human carcinomas: Diagnostic and experimental applications. Advances in immunohistochemistry, R. A DeLellis, et al. Raven Press, New York 1988; 165
   Google Scholar
• Thor A., Muraro R., Gorstein F., et al. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted CEA-reactivity. Cancer Res 1987; 47: 505
   PubMedGoogle Scholar
• Uotila M., Engvall R., Ruoslahti E. Monoclonal antibodies to human alpha-feto protein. Mol Irnmunol 1980; 17: 791
   Google Scholar
• Abelev G. Alpha-feto protein in ontogenesis and its association with malignant tumors. Adv Cancer Res 1971; 14: 295
   PubMedGoogle Scholar
• Sulitzeanu D. Human cancer-associated antigens: Present status and implications for immunodiagnosis. Adv Cancer Res 1985; 44: 1
   PubMedGoogle Scholar
• Koprowski H., Herlyn M., Steplewski Z, Sears HF. Specific antigen in serum of patients with colon carcinoma. Science 1981; 212: 53
   PubMed Web of Science ®Google Scholar
• Bast RC., Jr, Feaney M., Lazarus H., Nadler L. M, Colvin R. B, Knap RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 1331
   PubMed Web of Science ®Google Scholar
• Damjanov I., Knowles BB. Monoclonal antibodies and tumor-associated antigens. Lab Invest 1983; 48: 510
   PubMedGoogle Scholar
• Bennett J. M, Catowsky D., Daniel M. T, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Int Med 1985; 103: 620
   PubMed Web of Science ®Google Scholar
• Lennert K. Histopathology of non-Hodgkin's lymphomas (based on the Kiel classification). Springer-Verlag, New York 1981
   Google Scholar
• Stansfeld A. G, Diebold J., Kapanci Y. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292
   PubMed Web of Science ®Google Scholar
• Lukes R. J, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488
   PubMed Web of Science ®Google Scholar
• Foon K. A, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1
   PubMed Web of Science ®Google Scholar
• Stein H., Lenner K., Feller A. C, et al. Immunohistological analysis of human lymphoma: Correlation of histological and immunological categories. Adv Cancer Res 1984; 42: 67
   PubMed Web of Science ®Google Scholar
• Picker L., Weiss L. M, Medeiros L. J, Wood G. S, Warnke RA. Review article. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987; 128: 181
   PubMed Web of Science ®Google Scholar
• Hanis NL. The impact of molecular genetics on the study of lymphoid neoplasia. Lab Invest 1985; 53: 509
   PubMedGoogle Scholar
• Chan J. KC, Ng C. S, Hui PK. A simple guide to the terminology and application of leukocyte monoclonal antibodies. Histopathology 1988; 12: 461
   PubMed Web of Science ®Google Scholar
• Freedman A. S, Griffin J. D, Naddler LM. Leukemias and the ontogeny of leukocytes. Diagnostic immunopathology, R. P Colvin, A. K Bhan, R. T McClus-Key. Raven Press, New York 1988; 245
   Google Scholar
• Fetter FI. Flow cytometry. Diagnostic immunopathology, R. P Colvin, A. K Bhan, R. T McCluskey. Raven Press, New York 1988; 453
   Google Scholar
• Coon J. S, Landay A. L, Weinstein RS. Biology of disease. Advances in flow cytometry for diagnostic pathology. Lab Invest 1987; 57: 453
   PubMed Web of Science ®Google Scholar
• Pinkus GS. Leukocyte common antigen. Advances in immunohistochemistry, R. A DeLellis. Raven Press, New York 1988
   Google Scholar
• Warnke R. A, Gatter K. C, Falini B., et al. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med 1983; 309: 1275
   PubMed Web of Science ®Google Scholar
• Van der Reijden H. J, van Rhenen D. J, Lansdorp P. M, et al. Aomparison of surface marker analysis and FAB classification in acute myeloid leukemia. Blood 1983; 61: 443
   PubMed Web of Science ®Google Scholar
• Koike T., Aoki S., Maruyama S., et al. Cell surface phenotyp-ing of megakaryoplasts. Blood 1987; 69: 957
   PubMed Web of Science ®Google Scholar
• Innes D. J, Mills S. E, Walker GK. Megakaryocytic leukemia. Identification utilizing antifactor VIII immunoperoxidase. Am J Clin Pathol 1982; 77: 107
   PubMed Web of Science ®Google Scholar
• Gahmberg C. G, Jokinen M., Andersson LC. Expression of major sialoglycoprotein (glycophorin) on erythroid cells in human bone marrow. Blood 1978; 52: 379
   PubMedGoogle Scholar
• Villeval J. L, Cramer P., Lemoine F., et al. Phenotype of early erythroblastic leukemias. Blood 1986; 68: 1167
   PubMed Web of Science ®Google Scholar
• Linch D. C, Allen C., Beverley P. CL, Bynoe A. G, Scott C. S, Hogg N. Monoclonal antibodies differentiating between monocytic and non-monocytic variants of AML. Blood 1984; 63: 566
   PubMed Web of Science ®Google Scholar
• Soini Y., Miettinen M. Alpha- 1-antitrypsin and lysozyme. Their limited significance in fibrohistiocytic tumors. Am J Clin Pathol 1989; 91: 515
   PubMedGoogle Scholar
• Weiss L. M, Trela M. J, Cleary M. L, Turner R. R, Warnke R. A, Sklar J. Frequent immunoglobulin and T-cell receptor gene rearrangements in 'histiocytic' neoplasms. Am J Pathol 1985; 121: 369
   PubMed Web of Science ®Google Scholar
• Sobol R. E, Mick R., Royston I., et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 1987; 316: 111
   PubMed Web of Science ®Google Scholar
• Griffin J. D, Davis R., Nelson D. A, et al. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 1986; 68: 1232
   PubMed Web of Science ®Google Scholar
• Ritz J., Nadler L. M, Bhan A. K, Notis-McConarty J., Pesando J. M, Schlossman SF. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood 1981; 58: 648
   PubMed Web of Science ®Google Scholar
• Vogler L. B, Crist W. N, Bockman D. E, Pearl E. R, Lawton A. R, Cooper MD. Pre-B-cell leukemia. New phenotype of childhood lymphoblastic leukemia. N Engl J Med 1978; 298: 872
   PubMed Web of Science ®Google Scholar
• Stein H., Bonk A., Tolksdorf G., Lennert K., Rodf H., Gercles J. Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem 1980; 28: 746
   PubMed Web of Science ®Google Scholar
• Levy R., Warnke R., Dorfman R. F, Haimovich J. The monoclonality of human B-cell lymphomas. J Exp Med 1977; 145: 1014
   PubMed Web of Science ®Google Scholar
• Nadler L. M, Korsmeyer S. J, Anderson K. C, et al. B-cell orifin off non-T-cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 1984; 74: 332
   PubMed Web of Science ®Google Scholar
• Doggett R. S, Wood G. S, Homing S., et al. The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol 1984; 115: 245
   PubMed Web of Science ®Google Scholar
• Greaves M. F, Brown G., Rapson N. T, Lister AT. Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immuno-pathol 1975; 4: 67
   PubMedGoogle Scholar
• Letarte M., Vera S., Tran R., et al. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidose. J Exp Med 1988; 168: 1247
   PubMed Web of Science ®Google Scholar
• LeBien T. W, McCormack RT. The common acute lymphoblastic leukemia antigen (CD10)—Emancipation from a functional dilemma. Blood 1989; 73: 625
   PubMed Web of Science ®Google Scholar
• Freedman A. S, Gnfin J. D, Naddler LM. Leukemias and the ontogeny of leukocytes. Diagnostic immunopathology, R. P Colvin, A. K Bhan, R. T McCluskey. Raven Press, New York 1988; 245
   Google Scholar
• Prouet J-C., Valensy F., Daniel M-T, et al. Immunological classification of acute lymphoblastic leukemias: Evaluation of its clinical significance in 100 patients. Br J Haematol 1976; 33: 319
   PubMedGoogle Scholar
• Borowitz M. J, Dowell B. L, Boyett J. M, et al. Monoclonal antibody definition of T-cell acute leukemia: a pediatric oncology group study. Blood 1985; 65: 785
   PubMed Web of Science ®Google Scholar
• Link M., Warnke R., Finlay D., et al. A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Blood 1983; 2: 722
   Google Scholar
• Hams NL. Lymphoma 1987: An interim approach to diagnosis and classification. Pathol Annu 1987; 22: 1
   Google Scholar
• Gale R. P, Bassat IB. Hybrid acute leukaemia. Br J Haematol 1987; 65: 261
   PubMed Web of Science ®Google Scholar
• Ferraris A. M, Raskind W. H, Bjornson B. H, Jacobson R. J, Singer J. W, Fialkow PW. Heterogeneity of B-cell involvement in acute non-lymphocytic leukemia. Blood 1985; 66: 342
   PubMed Web of Science ®Google Scholar
• Weiss L. M, Bindl J. M, Picozzi V. J, Link M. P, Warnke RA. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T-cell acute lymphoblastic leukemia. Blood 1986; 67: 474
   PubMed Web of Science ®Google Scholar
• Knowles DM. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol 1989; 134: 761
   PubMed Web of Science ®Google Scholar
• Hakomori S-I. Apparent glycosylation in cancer cell membranes as focused on glycolipids: Overview and perspectives. Cancer Res 1985; 35: 2405
   Google Scholar
• Damjanov I. Lectin cytochemistry and histochemistry. Lab Invest 1987; 57: 5
   PubMed Web of Science ®Google Scholar
• Virtanen I., Lehtonen E., Nvanen O, Leivo I., Lehto V-P. Population heterogeneity in the surface expression of Ulex I-lectin (UEA It—Binding sites in cultured malignant and transformed cells. Exp Cell Res 1985; 161: 53
   PubMedGoogle Scholar
• Akoy J., Ucci A. A, Pereira M. EA. Lectins: Histochemical probes for specific carbohydrate residues. Diagnostic immunohistochemistry, R. A DeLellis. Masson Inc, New York 1984; 67
   Google Scholar
• Bishop JM. The molecular genetics of cancer. Science 1987; 235: 305
   PubMed Web of Science ®Google Scholar
• Pontén J. Oncogenes for the oncologist. Acta Oncol 1987; 26: 3
   PubMed Web of Science ®Google Scholar
• Yokota J., Tsunetsugu-Yokota Y., Battifora H., LeFevre C., Cline MJ. Alterations ofmyc, mybandrasHaproto-oncogenes in cancer are frequent and show clinical correlation. Science 1986; 231: 261
   PubMed Web of Science ®Google Scholar
• Merkel D. E, McGuire WL. Oncogenes and cancer prognosis. Important advances in oncology 1988, VT. DeVita, Jr, S. Hellman, S. A Rosenberg. 1988, JB Lippincott Co, New York, 103
   Google Scholar
• Chesa P. G, Rettig W. J, McLamed M. R, Old L. J, Niman HL. Expression of p21rasin normal and malignant human tissues: Lack of association with proliferation and malignancy. Proc Natl Acad Sci USA 1987; 84: 3234
   PubMed Web of Science ®Google Scholar
• Heldin C-H., Westermark B. Growth factors: Mechanism of action and relation to oncogenes. Cell 1984; 37: 9
   PubMed Web of Science ®Google Scholar
• King C. R, Kraus M. H, Aaronson SA. Amplification of a novel v-erb B-related gene in human mammary carcinoma. Science 1985; 229: 974
   PubMed Web of Science ®Google Scholar
• Slamon D. J, Clark G. N, Wong SG. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu-oncogene. Science 1987; 235: 177
   PubMed Web of Science ®Google Scholar
• Yokota J., Yamamoto T., Miyama N. Genetic alterations of the c-erb2 oncogene occur frequently in tubular adenocarci-noma of the stomach and are often accompanied by amplitication of the v-erba homologue. Oncogene 1988; 2: 283
   PubMed Web of Science ®Google Scholar
• Escot C., Theillet C., Lindereau R., et al. Genetic alterations of the c-myc proto-oncogene (myc) in human primary breast carcinomas. Proc Natl Acad Sci USA 1986; 83: 4834
   PubMed Web of Science ®Google Scholar
• Spandidos D. A, Agnantis NJ. Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the harveyrusoncogene. Anti-cancer Res 1984; 4: 269
   PubMed Web of Science ®Google Scholar
• Lidereau R., Callahan R., Dickson C., Peters G., Escot C., Ali IU. Amplification of theint-2gene in primary human breast tumors. Oncogene Res 1988; 2: 285
   PubMedGoogle Scholar
• Johnson B. E, Ihde D. C, Makuch R. W, et al. Myc-family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest 1987; 72: 1629
   Google Scholar
• Little C. D, Nau M. M, Carney D. N, Gazdar A. F, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983; 306: 194
   PubMed Web of Science ®Google Scholar
• Wong A. J, Bigner S. H, Bigner D. D, Kinzoer K. W, Hamilton S. R, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Roc Natl Acad Sci USA 1984; 84: 6899
   Google Scholar
• Riou G., Le M. G, LeDoussal V., Barrois M., George M., Haie C. c-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet 1987; 1: 761
   PubMed Web of Science ®Google Scholar
• Seeger R. C, Brodeur G. M, Sather H., et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111
   PubMed Web of Science ®Google Scholar
• Brodeur G. M, Seeger R. C, Schwab M., Varmus H. E, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121
   PubMed Web of Science ®Google Scholar
• Pastan I., Gottesman M. Multiple drug resistance in human cancer. N Engl J Med 1987; 316: 1388
   PubMed Web of Science ®Google Scholar
• Roninson I. B, Chin J. E, Choi K., et al. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB-carcinoma cells. Proc Natl Acad Sci USA 1986; 83: 4538
   PubMed Web of Science ®Google Scholar
• Ma D. DF, Davey R. A, Harman D. H, et al. Detection of a multidrug resistant phenotyge in acute nonlymphoblastic leukemia. Lancet 1987; 1: 135
   PubMed Web of Science ®Google Scholar
• Bell D. R, Gerlach J. H, Kartner N., Buick R. N, Ling V. Detection of P-glycoprotein in ovarian cancer: A molecular marker associated with multidrug-resistance. J Clin Immunol 1985; 3: 311
   Google Scholar
• Lee AK. Basement membrane and endothelial antigens: Their role in evaluation of tumor invasion and metastasis. Advances in immunohistochemistry, R. A DeLellis. Raven Press, New York 1988; 363
   Google Scholar
• D'Ardenne AJ. Review: Use of basement membrane markers in tumour diagnosis. J Clin Pathol 1989; 42: 449
   PubMedGoogle Scholar
• Martinez-Hernandez A., Amenta PS. The basement membrane in pathology. Lab Invest 1983; 48: 656
   PubMed Web of Science ®Google Scholar
• Kallioinen M., Autio-Harmainen H., Dammert K., Risteli J., Risteli L. Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquarnous carcinomas of the skin. An immunohistochemical study with human laminin and type IV collagen antibodies. J Invest Dermatol 1984; 82: 248
   PubMed Web of Science ®Google Scholar
• Stenback F., Wasenius V-M. Occurrence of basement membranes in pigment cell tumors of the skin. Relation to cell type and clinical behavior. J Cutan Pathol 1986; 13: 175
   PubMedGoogle Scholar
• Stenback F., Risteli J., Risteli L., Wasenius V-M. Basement membrane laminin and type IV collagen in endometrial adenocarcinoma. Relation to differentiation and treatment. Oncology 1985; 42: 370
   PubMedGoogle Scholar
• Ekblom P., Miettinen M., Forsman L., Anderson LC. Basement membrane and apocrine epithelial antigens in differential diagnosis between tubular carcinoma and sclerosing adenosis of the breast. J Clin Pathol 1984; 37: 357
   PubMed Web of Science ®Google Scholar
• Miettinen M., Foidort J. M, Ekblom P. Immunohistochemical demonstration of laminin, the major glycoprotein of basement membranes as an aid to the diagnosis of soft tissue tumours. Am J Clin Pathol 1983; 79: 306
   PubMed Web of Science ®Google Scholar
• Liotta L. A, Thorgeirsson U. P, Garbisa S. Role of collage-nases in tumor cell invasion. Cancer Metast Rev 1982; 1: 277
   PubMedGoogle Scholar
• Liotta L. A, Tryggvason K., Garbisa S., Hart I., Foltz C. M, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67
   PubMed Web of Science ®Google Scholar
• Jalkanen S., Reichert R., Gallatin W. MG, Weissman I. L, Butcher EC. Homing receptors and the control of lymphocyte migration. Immunol Rev 1986; 91: 39
   PubMed Web of Science ®Google Scholar
• Nicolson G. L, Dulski KM. Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 1986; 38: 289
   PubMedGoogle Scholar
• Liotta LA. Tumor invasion and metastasis—role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 1986; 46: 1
   PubMed Web of Science ®Google Scholar
• Gerdes J., Lemke H., Baisch H., Wacker H-H, Schwab U., Stein H. Cell cycle analysis of a cell-proliferation. Associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710
   PubMed Web of Science ®Google Scholar
• Heppner GH. Tumor heterogeneity. Cancer Res 1984; 44: 2259
   PubMed Web of Science ®Google Scholar